Canada markets closed

Swedish Orphan Biovitrum AB (publ) (SOBIS.XC)

Cboe UK - Cboe UK Real Time Price. Currency in SEK
Add to watchlist
264.900.00 (0.00%)
At close: 03:16PM BST
Currency in SEK

Valuation Measures4

Market Cap (intraday) 97.88B
Enterprise Value 116.58B
Trailing P/E 41.91
Forward P/E 26.18
PEG Ratio (5 yr expected) 1.29
Price/Sales (ttm)3.82
Price/Book (mrq)2.51
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.25
52-Week Change 311.63%
S&P500 52-Week Change 326.27%
52 Week High 3290.60
52 Week Low 3185.25
50-Day Moving Average 3262.71
200-Day Moving Average 3244.54

Share Statistics

Avg Vol (3 month) 310
Avg Vol (10 day) 3N/A
Shares Outstanding 5339.87M
Implied Shares Outstanding 6363.86M
Float 8198.7M
% Held by Insiders 110.08%
% Held by Institutions 173.78%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 9.26%
Operating Margin (ttm)23.47%

Management Effectiveness

Return on Assets (ttm)4.51%
Return on Equity (ttm)6.72%

Income Statement

Revenue (ttm)23.14B
Revenue Per Share (ttm)69.38
Quarterly Revenue Growth (yoy)19.40%
Gross Profit (ttm)N/A
EBITDA 7.77B
Net Income Avi to Common (ttm)2.14B
Diluted EPS (ttm)6.33
Quarterly Earnings Growth (yoy)-25.00%

Balance Sheet

Total Cash (mrq)527M
Total Cash Per Share (mrq)1.55
Total Debt (mrq)19.22B
Total Debt/Equity (mrq)53.54%
Current Ratio (mrq)0.71
Book Value Per Share (mrq)105.59

Cash Flow Statement

Operating Cash Flow (ttm)4.74B
Levered Free Cash Flow (ttm)2.69B